Lisata Therapeutics Inc./$LSTA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
Ticker
$LSTA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
26
ISIN
US1280583022
Website
LSTA Metrics
BasicAdvanced
$23M
-
-$2.30
0.95
-
Price and volume
Market cap
$23M
Beta
0.95
52-week high
$2.87
52-week low
$1.87
Average daily volume
13K
Financial strength
Current ratio
7.517
Quick ratio
6.983
Total debt to equity
0.367
Management effectiveness
Return on assets (TTM)
-35.05%
Return on equity (TTM)
-56.92%
Valuation
Price to revenue (TTM)
22.612
Price to book
0.91
Price to tangible book (TTM)
0.92
Price to free cash flow (TTM)
-1.273
Growth
Earnings per share change (TTM)
-6.66%
3-year earnings per share growth (CAGR)
-27.04%
LSTA News
AllArticlesVideos
Lisata eyes key trial milestones in 2025 as certepetide development gains momentum
Proactive Investors·1 month ago
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewsWire·1 month ago
Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Lisata Therapeutics Inc. stock?
Lisata Therapeutics Inc. (LSTA) has a market cap of $23M as of June 09, 2025.
What is the P/E ratio for Lisata Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Lisata Therapeutics Inc. (LSTA) stock is 0 as of June 09, 2025.
Does Lisata Therapeutics Inc. stock pay dividends?
No, Lisata Therapeutics Inc. (LSTA) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Lisata Therapeutics Inc. dividend payment date?
Lisata Therapeutics Inc. (LSTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Lisata Therapeutics Inc.?
Lisata Therapeutics Inc. (LSTA) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.